Company profile: Nexelis
1.1 - Company Overview
Company description
- Provider of assay development and advanced laboratory testing; a portfolio company of Ampersand Capital Partners.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nexelis
Girindus
HQ: Germany
Website
- Description: Provider of solid-phase oligonucleotide manufacturing and customer-driven services for pharmaceutical clients, including process development, analytical method development, radiolabeling, cGMP-compliant scale-up, active ingredient manufacturing, and regulatory support, with expertise in both oligonucleotide and small molecule.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Girindus company profile →
VaLogic
HQ: United States
Website
- Description: Provider of facility management solutions for pharma, biotech, and life sciences, delivering GxP compliance services (calibration, commissioning, qualification, validation, environmental monitoring), CQV, GMP environmental monitoring (air, surface, water, lab gases), cleanroom and biosafety cabinet certification, comprehensive calibration, and the LogiPoint continuous monitoring system for critical environments and equipment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VaLogic company profile →
START Research
HQ: United States
Website
- Description: Provider of oncology and biotechnology research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full START Research company profile →
Inclinix
HQ: United States
Website
- Description: Provider of customized Phase I-IV clinical trial enrollment solutions for pharmaceutical, biotechnology, and medical device organizations. A division of Inclinix-PMG Holdings, Inc., Inclinix combines the sites of PMG Research Inc. with premier patient recruitment solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inclinix company profile →
Defence Therapeutics
HQ: Canada
Website
- Description: Provider of biopharmaceutical innovations leveraging Accum™ technology, a drug delivery platform that enhances delivery of therapeutic agents to target cells to improve efficacy for cancer and infectious diseases. Offerings include cancer therapeutics, vaccine development for infectious diseases and cancers, antibody-drug conjugates, AccuTOX, and the ARM-002 anti-cancer vaccine shown effective in pre-clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Defence Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nexelis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nexelis
2.2 - Growth funds investing in similar companies to Nexelis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nexelis
4.2 - Public trading comparable groups for Nexelis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →